Zohreh Amoozgar

机构：Harvard University, Massachusetts General Hospital, Sanofi (United States) · ORCID：0000-0001-8285-8024

发表论文 182 篇 · 总被引 8542 次 · h-index 37

代表论文

• Single cell RNA sequencing improves the next generation of approaches to AML treatment: challenges and perspectives (2025 · Molecular Medicine · 被引 15)
• Wnt inhibition alleviates resistance to anti-PD1 therapy and improves antitumor immunity in glioblastoma (2025 · Proceedings of the National Academy of Sciences · 被引 8)
• Therapeutic and prognostic values of ferroptosis signature in glioblastoma (2025 · International Immunopharmacology · 被引 6)
• Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma (2025 · Proceedings of the National Academy of Sciences · 被引 5)
• Macrophages recruited by implanted fibrin gels promote regeneration of injured lymphatic vessels (2026 · Scientific Reports · 被引 1)
• Dual Immunoliposome Targeting of PD-L1 and CSF1R affects T-Cell readouts in tumor-conditioned co‑cultures: An In Vitro Study in Glioblastoma and Medulloblastoma (2026 · bioRxiv (Cold Spring Harbor Laboratory))